Old	New	Differences
1	1
2	2
3	3
4	4	Req. No. 130 Page 1 1
5	5	2
6	6	3
7	7	4
8	8	5
9	9	6
10	10	7
11	11	8
12	12	9
13	13	10
14	14	11
15	15	12
16	16	13
17	17	14
18	18	15
19	19	16
20	20	17
21	21	18
22	22	19
23	23	20
24	24	21
25	25	22
26	26	23
27	27	24
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14
42	42	15
43	43	16
44	44	17
45	45	18
46	46	19
47	47	20
48	48	21
49	49	22
50	50	23
51	51	24
52	52
53	53	STATE OF OKLAHOMA
54	54
55	55	1st Session of the 60th Legislature (2025)
56	56
57	57	SENATE BILL 27 By: Bullard
58	58
59	59
60	60
61	61
62	62
63	63	AS INTRODUCED
64	64
65	65	An Act relating to controlled dangerous substances;
66	66	amending 63 O.S. 2021, Section 2 -309, as last amended
67	67	by Section 6, Chapter 308, O.S. L. 2024 (63 O.S. Supp.
68	68	2024, Section 2-309), which relates to prescriptions;
69	69	exempting certain practitioners from electronic
70	70	prescription requirement; limiting availability of
71	71	exemption; directing licensing boards to take certain
72	72	actions; updating statutory language; and providing
73	73	an effective date.
74	74
75	75
76	76
77	77	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
78	78	SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -309, as
79	79	last amended by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
80	80	2024, Section 2-309), is amended to read as follows:
81	81	Section 2-309. A. 1. Except for dosages medically required
82	82	for a period not to exceed forty -eight (48) hours which are
83	83	administered by or on direction of a practitioner, other than a
84	84	pharmacist, or medication dispensed directly by a practitioner,
85	85	other than a pharmacist, to a n ultimate user, no controlled
86	86	dangerous substance included in Schedule II, which is a prescription
87	87	drug as determined under regulation promulgated by the State Board
88	88	of Pharmacy, shall be dispensed without an electronic prescription
89	89
90	90
91	91	Req. No. 130 Page 2 1
92	92	2
93	93	3
94	94	4
95	95	5
96	96	6
97	97	7
98	98	8
99	99	9
100	100	10
101	101	11
102	102	12
103	103	13
104	104	14
105	105	15
106	106	16
107	107	17
108	108	18
109	109	19
110	110	20
111	111	21
112	112	22
113	113	23
114	114	24
115	115	1
116	116	2
117	117	3
118	118	4
119	119	5
120	120	6
121	121	7
122	122	8
123	123	9
124	124	10
125	125	11
126	126	12
127	127	13
128	128	14
129	129	15
130	130	16
131	131	17
132	132	18
133	133	19
134	134	20
135	135	21
136	136	22
137	137	23
138	138	24
139	139
140	140	of a practitioner; provided, that in emergency situations, as
141	141	prescribed by the State Board of Pharmacy by regulation, such drug
142	142	may be dispensed upon oral prescription reduced promptly to writing
143	143	and filed by the pharmacist in a manner to be prescribed by rules
144	144	and regulations of the Director of the Oklahoma State Bureau of
145	145	Narcotics and Dangerous Drugs Control.
146	146	2. Electronic prescribing shall be utilized for Schedules II,
147	147	III, IV and V, subject to th e requirements set forth in 21 CFR,
148	148	Section 1311 et seq.
149	149	3. An electronic prescription with electronic signature may
150	150	serve as an original prescription, subject to the requirements set
151	151	forth in 21 CFR, Section 1311 et seq.
152	152	4. Prescriptions shall be retain ed in conformity with the
153	153	requirements of this section and Section 2 -307 of this title. No
154	154	prescription for a Schedule II substance may be refilled.
155	155	5. The electronic prescription requirement provided for in this
156	156	section shall not apply to prescriptions for controlled dangerous
157	157	substances issued by any of the following:
158	158	a. a person licensed to practice veterinary medicine,
159	159	b. a practitioner who experiences temporary technological
160	160	or electrical failure or other extenuating
161	161	circumstance that prevents the pr escription from being
162	162	transmitted electronically; provided, however, that
163	163
164	164
165	165	Req. No. 130 Page 3 1
166	166	2
167	167	3
168	168	4
169	169	5
170	170	6
171	171	7
172	172	8
173	173	9
174	174	10
175	175	11
176	176	12
177	177	13
178	178	14
179	179	15
180	180	16
181	181	17
182	182	18
183	183	19
184	184	20
185	185	21
186	186	22
187	187	23
188	188	24
189	189	1
190	190	2
191	191	3
192	192	4
193	193	5
194	194	6
195	195	7
196	196	8
197	197	9
198	198	10
199	199	11
200	200	12
201	201	13
202	202	14
203	203	15
204	204	16
205	205	17
206	206	18
207	207	19
208	208	20
209	209	21
210	210	22
211	211	23
212	212	24
213	213
214	214	the practitioner documents the reason for this
215	215	exception in the medical record of the patient,
216	216	c. a practitioner, other than a pharmacist, who dispenses
217	217	directly to an ultimate user,
218	218	d. a practitioner who orders a controlled dangerous
219	219	substance to be administered through an on -site
220	220	pharmacy in:
221	221	(1) a hospital as defined in Section 1 -701 of this
222	222	title,
223	223	(2) a nursing facility as defined in Section 1 -1902
224	224	of this title,
225	225	(3) a hospice inpatient facility as defined in
226	226	Section 1-860.2 of this title,
227	227	(4) an outpatient dialysis facility,
228	228	(5) a continuum of care facility as defined in
229	229	Section 1-890.2 of this title, or
230	230	(6) a penal institution listed in Section 509 of
231	231	Title 57 of the Oklahoma Sta tutes,
232	232	e. a practitioner who orders a controlled dangerous
233	233	substance to be administered through a hospice program
234	234	including, but not limited to, a hospice program that
235	235	provides hospice services in the private residence of
236	236	a patient or in a long -term care facility where the
237	237	patient resides. As used in this subparagraph,
238	238
239	239
240	240	Req. No. 130 Page 4 1
241	241	2
242	242	3
243	243	4
244	244	5
245	245	6
246	246	7
247	247	8
248	248	9
249	249	10
250	250	11
251	251	12
252	252	13
253	253	14
254	254	15
255	255	16
256	256	17
257	257	18
258	258	19
259	259	20
260	260	21
261	261	22
262	262	23
263	263	24
264	264	1
265	265	2
266	266	3
267	267	4
268	268	5
269	269	6
270	270	7
271	271	8
272	272	9
273	273	10
274	274	11
275	275	12
276	276	13
277	277	14
278	278	15
279	279	16
280	280	17
281	281	18
282	282	19
283	283	20
284	284	21
285	285	22
286	286	23
287	287	24
288	288
289	289	“hospice program” has the same meaning as provided by
290	290	Section 1-860.2 of this title,
291	291	f. a practitioner who writes a prescription to be
292	292	dispensed by a pharmacy located on federal property,
293	293	provided the practitioner documents the reason for
294	294	this exception in the medical record of the patient,
295	295	g. a practitioner that has received a waiver or extension
296	296	from his or her licensing board,
297	297	h. a practitioner who prescribes a controlled dangerous
298	298	substance for a supply that when taken as prescribed
299	299	would be consumed within sevent y-two (72) hours, or
300	300	i. a practitioner who determines that an electronic
301	301	prescription cannot be issued in a timely manner and
302	302	the condition of the patient is at risk , or
303	303	j a practitioner who practices exclusively in one or
304	304	more medically underserved areas (MUAs) as designated
305	305	by the Health Resources and Services Administration.
306	306	This exemption shall not be available to a
307	307	practitioner who has been subject to disciplinary
308	308	action by the practitioner’s licensing board for a
309	309	violation related to the prescription of controlled
310	310	dangerous substances. The licensing board shall
311	311	communicate with and share necessary information with
312	312	the Oklahoma State Bureau of Narcotics and Dangerous
313	313
314	314
315	315	Req. No. 130 Page 5 1
316	316	2
317	317	3
318	318	4
319	319	5
320	320	6
321	321	7
322	322	8
323	323	9
324	324	10
325	325	11
326	326	12
327	327	13
328	328	14
329	329	15
330	330	16
331	331	17
332	332	18
333	333	19
334	334	20
335	335	21
336	336	22
337	337	23
338	338	24
339	339	1
340	340	2
341	341	3
342	342	4
343	343	5
344	344	6
345	345	7
346	346	8
347	347	9
348	348	10
349	349	11
350	350	12
351	351	13
352	352	14
353	353	15
354	354	16
355	355	17
356	356	18
357	357	19
358	358	20
359	359	21
360	360	22
361	361	23
362	362	24
363	363
364	364	Drugs Control for the purpose of enforcement of this
365	365	subparagraph.
366	366	6. Electronic prescriptions may be utilized under the following
367	367	circumstances:
368	368	a. compounded prescriptions,
369	369	b. compounded infusion prescriptions, or
370	370	c. prescriptions issued under approved research
371	371	protocols.
372	372	7. A pharmacist who receives a written, oral or facsimile
373	373	prescription shall not be required to verify that the prescription
374	374	falls under one of the exceptions provided for in paragraph 6 of
375	375	this subsection. Pharmacists may continue to dispens e medications
376	376	from otherwise valid written, oral or facsimile prescriptions that
377	377	are consistent with the provisions of this section.
378	378	8. Practitioners shall indicate in the health record of a
379	379	patient that an exception to the electronic prescription require ment
380	380	was utilized.
381	381	9. All prescriptions issued pursuant to paragraph 5 and
382	382	subparagraph c of paragraph 6 of this subsection shall be on an
383	383	official prescription form approved by the Oklahoma State Bureau of
384	384	Narcotics and Dangerous Drugs Control if not iss ued electronically.
385	385	10. a. Practitioners shall be registered with the Oklahoma
386	386	State Bureau of Narcotics and Dangerous Drugs Control
387	387	in order to purchase official prescription forms.
388	388
389	389
390	390	Req. No. 130 Page 6 1
391	391	2
392	392	3
393	393	4
394	394	5
395	395	6
396	396	7
397	397	8
398	398	9
399	399	10
400	400	11
401	401	12
402	402	13
403	403	14
404	404	15
405	405	16
406	406	17
407	407	18
408	408	19
409	409	20
410	410	21
411	411	22
412	412	23
413	413	24
414	414	1
415	415	2
416	416	3
417	417	4
418	418	5
419	419	6
420	420	7
421	421	8
422	422	9
423	423	10
424	424	11
425	425	12
426	426	13
427	427	14
428	428	15
429	429	16
430	430	17
431	431	18
432	432	19
433	433	20
434	434	21
435	435	22
436	436	23
437	437	24
438	438
439	439	Such registration shall include, but not be limited
440	440	to, the primary addr ess and the address of each place
441	441	of business to be imprinted on official pre scription
442	442	forms. Any change to a registered practitioner ’s
443	443	registered address shall be promptly reported to the
444	444	practitioner’s licensing board and the Bureau by the
445	445	practitioner in a manner approved by the Bureau.
446	446	b. Where the Bureau has revoked the registration of a
447	447	registered practitioner, the Bureau may revoke or
448	448	cancel any official prescription forms in the
449	449	possession of the registered practitioner. Any
450	450	revocation or any susp ension shall require the
451	451	registered practitioner to return all unused officia l
452	452	prescription forms to the Bureau within fifteen (15)
453	453	calendar days after the date of the written
454	454	notification.
455	455	c. A practitioner that has had any license to practice
456	456	terminated, revoked or suspended by a state or federal
457	457	agency may, upon restoration of such license or
458	458	certificate, register with the Bureau.
459	459	11. a. Official prescription forms shall be purchased at the
460	460	expense of the practitioner or the employer of the
461	461	practitioner from a list of vendors approved by the
462	462	Bureau.
463	463
464	464
465	465	Req. No. 130 Page 7 1
466	466	2
467	467	3
468	468	4
469	469	5
470	470	6
471	471	7
472	472	8
473	473	9
474	474	10
475	475	11
476	476	12
477	477	13
478	478	14
479	479	15
480	480	16
481	481	17
482	482	18
483	483	19
484	484	20
485	485	21
486	486	22
487	487	23
488	488	24
489	489	1
490	490	2
491	491	3
492	492	4
493	493	5
494	494	6
495	495	7
496	496	8
497	497	9
498	498	10
499	499	11
500	500	12
501	501	13
502	502	14
503	503	15
504	504	16
505	505	17
506	506	18
507	507	19
508	508	20
509	509	21
510	510	22
511	511	23
512	512	24
513	513
514	514	b. Official prescription forms issued to a registered
515	515	practitioner shall be imprinted with the primary
516	516	address and may include other addresses listed on the
517	517	registration of the practitioner to identify the pla ce
518	518	of origin. Such prescriptions shall be sent only to
519	519	the primary address of the registered practitioner.
520	520	c. Official prescription forms of a registered
521	521	practitioner shall be used only by the practitioner
522	522	designated on the official prescription form.
523	523	d. The Bureau may revoke or cancel official prescription
524	524	forms in the possession of a registered practitioners
525	525	practitioner when the license of such practitioner is
526	526	suspended, terminated or revoked.
527	527	e. Official prescription forms of registered
528	528	practitioners who are deceased or who no longer
529	529	prescribe shall be returned to the Bureau at a
530	530	designated address. If the registered practitioner is
531	531	deceased, it is the responsibility of the registered
532	532	practitioner’s estate or lawful designee to return
533	533	such forms.
534	534	f. The Bureau may issue official prescription forms to
535	535	employees or agents of the Bureau and other government
536	536	agencies for the purpose of preventing, identifying,
537	537	investigating and prosecuting unacceptable or illegal
538	538
539	539
540	540	Req. No. 130 Page 8 1
541	541	2
542	542	3
543	543	4
544	544	5
545	545	6
546	546	7
547	547	8
548	548	9
549	549	10
550	550	11
551	551	12
552	552	13
553	553	14
554	554	15
555	555	16
556	556	17
557	557	18
558	558	19
559	559	20
560	560	21
561	561	22
562	562	23
563	563	24
564	564	1
565	565	2
566	566	3
567	567	4
568	568	5
569	569	6
570	570	7
571	571	8
572	572	9
573	573	10
574	574	11
575	575	12
576	576	13
577	577	14
578	578	15
579	579	16
580	580	17
581	581	18
582	582	19
583	583	20
584	584	21
585	585	22
586	586	23
587	587	24
588	588
589	589	practices by providers and other persons and assisting
590	590	in the recovery of overpayments under any program
591	591	operated by the state or paid for with state funds.
592	592	Such prescription forms shall be issued for this
593	593	purpose only to individuals who are authorized to
594	594	conduct investigations on behalf of the Bur eau or
595	595	other government agencies as part of their official
596	596	duties. Individuals and agencies receiving such
597	597	prescription forms for this purpose shall provide
598	598	appropriate assurances to the Bureau that adequate
599	599	safeguards and security measures are in place t o
600	600	prevent the use of such prescription forms for
601	601	anything other than official government purposes.
602	602	12. a. Adequate safeguards and security measures shall be
603	603	undertaken by registered practitioners holding
604	604	official prescription forms to assure against the
605	605	loss, destruction, theft or unauthorized use of the
606	606	forms. Registered practiti oners shall maintain a
607	607	sufficient but not excessive supply of such forms in
608	608	reserve.
609	609	b. Registered practitioners shall immediately notify the
610	610	Bureau, in a manner designated by the Bureau, upon
611	611	their knowledge of the loss, destruction, theft or
612	612	unauthorized use of any official prescription forms
613	613
614	614
615	615	Req. No. 130 Page 9 1
616	616	2
617	617	3
618	618	4
619	619	5
620	620	6
621	621	7
622	622	8
623	623	9
624	624	10
625	625	11
626	626	12
627	627	13
628	628	14
629	629	15
630	630	16
631	631	17
632	632	18
633	633	19
634	634	20
635	635	21
636	636	22
637	637	23
638	638	24
639	639	1
640	640	2
641	641	3
642	642	4
643	643	5
644	644	6
645	645	7
646	646	8
647	647	9
648	648	10
649	649	11
650	650	12
651	651	13
652	652	14
653	653	15
654	654	16
655	655	17
656	656	18
657	657	19
658	658	20
659	659	21
660	660	22
661	661	23
662	662	24
663	663
664	664	issued to them, as well as the failure to receive
665	665	official prescription forms within a reasonable time
666	666	after ordering them from the Bureau.
667	667	c. Registered practitioners shall immediately notify the
668	668	Bureau upon their knowledge of any diversion or
669	669	suspected diversion of drugs pursuant to the loss,
670	670	theft or unauthorized use of prescriptions.
671	671	B. 1. Except for dosages medically required for a per iod not
672	672	to exceed seventy-two (72) hours which are administered by or on
673	673	direction of a practitioner other than a pharmacist or medication
674	674	dispensed directly by a practitioner, other than a pharmacist, to an
675	675	ultimate user, or the circumstances provided for in paragraphs 5 and
676	676	6 of subsection A of this section, no controlled dangero us substance
677	677	included in Schedule III or IV, which is a prescription drug as
678	678	determined under regulation promulgated by the State Board of
679	679	Pharmacy, shall be dispensed without an electronic prescription.
680	680	2. Any prescription for a controlled dangerous substance in
681	681	Schedule III, IV or V may not be filled or refilled more than six
682	682	(6) months after the date thereof or be refilled more than five
683	683	times after the date of the prescription , unless renewed by the
684	684	practitioner.
685	685	C. Whenever it appears to the Director of the Oklahoma State
686	686	Bureau of Narcotics and Dangerous Drugs Control that a drug not
687	687	considered to be a prescription drug under existing state law or
688	688
689	689
690	690	Req. No. 130 Page 10 1
691	691	2
692	692	3
693	693	4
694	694	5
695	695	6
696	696	7
697	697	8
698	698	9
699	699	10
700	700	11
701	701	12
702	702	13
703	703	14
704	704	15
705	705	16
706	706	17
707	707	18
708	708	19
709	709	20
710	710	21
711	711	22
712	712	23
713	713	24
714	714	1
715	715	2
716	716	3
717	717	4
718	718	5
719	719	6
720	720	7
721	721	8
722	722	9
723	723	10
724	724	11
725	725	12
726	726	13
727	727	14
728	728	15
729	729	16
730	730	17
731	731	18
732	732	19
733	733	20
734	734	21
735	735	22
736	736	23
737	737	24
738	738
739	739	regulation of the State Board of Pharmacy should be so considered
740	740	because of its abuse potential, the Director shall so advise the
741	741	State Board of Pharmacy and furnish to the Board all available data
742	742	relevant thereto.
743	743	D. 1. “Prescription”, as used in this section, means a
744	744	written, oral or electronic order by a practitioner to a pharmacist
745	745	for a controlled dangerous substance for a particular patient, which
746	746	specifies the date of its issue, and the full name and address of
747	747	the patient and, if the controlled dangerous substance is pres cribed
748	748	for an animal, the species of the animal, the name and quantity of
749	749	the controlled dangerous substance prescribed, the directions for
750	750	use, the name and address of the owner of the animal and, if
751	751	written, the signature of the practitioner. When elect ronically
752	752	prescribed, the full name of the patient may include the name and
753	753	species of the animal.
754	754	2. “Registered practitioner ”, as used in this section, means a
755	755	licensed practitioner duly registered with the Oklahoma State Bureau
756	756	of Narcotics and Dangero us Drugs Control authorized to purchase
757	757	official prescription forms.
758	758	E. No person shall solicit, dispense, receive or deliver any
759	759	controlled dangerous substance through the mail, unless the ultimate
760	760	user is personally known to the practitioner and circums tances
761	761	clearly indicate such method of delivery is in the best interest of
762	762	the health and welfare of the ultimate user.
763	763
764	764
765	765	Req. No. 130 Page 11 1
766	766	2
767	767	3
768	768	4
769	769	5
770	770	6
771	771	7
772	772	8
773	773	9
774	774	10
775	775	11
776	776	12
777	777	13
778	778	14
779	779	15
780	780	16
781	781	17
782	782	18
783	783	19
784	784	20
785	785	21
786	786	22
787	787	23
788	788	24
789	789	1
790	790	2
791	791	3
792	792	4
793	793	5
794	794	6
795	795	7
796	796	8
797	797	9
798	798	10
799	799	11
800	800	12
801	801	13
802	802	14
803	803	15
804	804	16
805	805	17
806	806	18
807	807	19
808	808	20
809	809	21
810	810	22
811	811	23
812	812	24
813	813
814	814	SECTION 2. This act shall become effective November 1, 2025.
815	815
816	816	60-1-130 DC 12/16/2024 10:49:16 AM

Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB27 Compare Versions